Measurable Residual Disease (MRD) Detection by Next Generation Sequencing (NGS) in Acute Lymphoblastic LEUKAEMIA (ALL)
Pathology - United States
doi 10.1016/j.pathol.2020.01.369
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Elsevier BV